Search research articles
Contact Us
Filters
Showing results (101-110 of 305) with videos related to
Page
of 31
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models
T Reissmann, R Voegeli, J Pohl, et al.
FEBS Letters
|
June 1, 1982
Identification of the active site cysteine and of the disulfide bonds in the N-terminal part of the molecule of bovine spleen cathepsin B
J Pohl, M Baudys, V Tomásek, et al.
Plos Genetics
|
May 17, 2012
Functional centromeres determine the activation time of pericentric origins of DNA replication in Saccharomyces cerevisiae
Thomas J Pohl, Bonita J Brewer, M K Raghuraman
The Nurse Practitioner
|
October 4, 2000
Cost-effectiveness analysis: an essential tool for practice management
D Vincent, D Oakley, J Pohl, et al.
Das Deutsche Gesundheitswesen
|
April 27, 1972
[Studies of the pattern of free fatty acids in the blood plasma of rabbits in experimental nephrogenic hypertension and following administration of angiotensin II]
M L Michailov, S Nitschkoff, J Pohl, et al.
Health Physics
|
August 1, 1983
Radiation exposure of the respiratory tract and associated carcinogenic risk due to inhaled radon daughters
F Steinhäusler, W Hofmann, E Pohl, et al.
Infection and Immunity
|
November 1, 1996
Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content
W M Shafer, F Hubalek, M Huang, et al.
Clinical & Experimental Metastasis
|
May 1, 1988
Oncogene expression in related cancer lines differing in metastatic capacity
J Pohl, A Radler-Pohl, R Heicappell, et al.
Biochemical and Biophysical Research Communications
|
January 17, 1995
Cloning of a new member of the TGF-beta family: a putative new activin beta C chain
G H tten, H Neidhardt, C Schneider, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Induction of the metastatic phenotype by transfection of the nuclear oncogene p53: increases in cytoplasmic diacylglycerol levels and reduction in class I major histocompatibility antigen expression are not sufficient to explain the changes in metastatic capacities
J Pohl, V Lehmann, A Radler-Pohl, et al.
Page
of 31
Search research articles
Search
Showing results (101-110 of 305) with videos related to
Sort By:
Page
of 31
Cancer Immunology, Immunotherapy : CII
|
January 1, 1989
Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models
T Reissmann, R Voegeli, J Pohl, et al.
FEBS Letters
|
June 1, 1982
Identification of the active site cysteine and of the disulfide bonds in the N-terminal part of the molecule of bovine spleen cathepsin B
J Pohl, M Baudys, V Tomásek, et al.
Plos Genetics
|
May 17, 2012
Functional centromeres determine the activation time of pericentric origins of DNA replication in Saccharomyces cerevisiae
Thomas J Pohl, Bonita J Brewer, M K Raghuraman
The Nurse Practitioner
|
October 4, 2000
Cost-effectiveness analysis: an essential tool for practice management
D Vincent, D Oakley, J Pohl, et al.
Das Deutsche Gesundheitswesen
|
April 27, 1972
[Studies of the pattern of free fatty acids in the blood plasma of rabbits in experimental nephrogenic hypertension and following administration of angiotensin II]
M L Michailov, S Nitschkoff, J Pohl, et al.
Health Physics
|
August 1, 1983
Radiation exposure of the respiratory tract and associated carcinogenic risk due to inhaled radon daughters
F Steinhäusler, W Hofmann, E Pohl, et al.
Infection and Immunity
|
November 1, 1996
Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content
W M Shafer, F Hubalek, M Huang, et al.
Clinical & Experimental Metastasis
|
May 1, 1988
Oncogene expression in related cancer lines differing in metastatic capacity
J Pohl, A Radler-Pohl, R Heicappell, et al.
Biochemical and Biophysical Research Communications
|
January 17, 1995
Cloning of a new member of the TGF-beta family: a putative new activin beta C chain
G H tten, H Neidhardt, C Schneider, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Induction of the metastatic phenotype by transfection of the nuclear oncogene p53: increases in cytoplasmic diacylglycerol levels and reduction in class I major histocompatibility antigen expression are not sufficient to explain the changes in metastatic capacities
J Pohl, V Lehmann, A Radler-Pohl, et al.
Page
of 31